RAGE, LDL receptor, and LRP1 expression in the brains of SAMP8

Neuroscience Letters

Volumn 461, Issue 2, 2009, Pages 100-105

  Wu, Bin ^a,b   Ueno, Masaki ^a   Onodera, Masayuki ^a   Kusaka, Takashi ^a   Huang, Cheng long ^a   Hosomi, Naohisa ^a   Kanenishi, Kenji ^a   Sakamoto, Haruhiko ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

BBB; LDLR; LRP1; RAGE; SAM

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE ACCELERATED MOUSE; WESTERN BLOTTING;

AGING; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ASTROCYTES; BRAIN; ENDOTHELIAL CELLS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICROSCOPY, CONFOCAL; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LDL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEINS;

EID: 67649644716     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.06.013     Document Type: Article

References (41)

1. Abdulkarim Y., and Hameed Z. Is the LDL receptor involved in cortical amyloid protein clearance?. Neurochem. Res. 31 (2006) 839-847
2. Alvarez-Garcia O., Vega-Naredo I., Sierra V., Caballero B., Tomas-Zapico C., Camins A., Garcia J.J., Palla M., and Coto-Montes A. Elevated oxidative stress in the brain of senescence-accelerated mice at 5 months of age. Biogerontology 7 (2006) 43-52
3. Brett J., Schmidt A.M., Zou Y.S., Yan S.D., Weidman E., Pinsky D.J., Neeper M., Przysiecki M., Shaw A., Migheli A., and Stern D.M. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am. J. Pathol. 143 (1993) 1699-1712
4. Cao D., Fukuchi K., Wan H., Kim H., and Li L. Lack of LDL receptor aggravates learning and amyloid deposits in Alzheimer transgenic mice. Neurobiol. Aging 27 (2006) 1632-1643
5. Catar R.A., Muller G., Heidler J., Schmitz G., Bornstein S.R., and Morawietz H. Low-density lipoproteins induce the rennin-angiotension system and their receptors in human endothelial cells. Horm. Metab. Res. 39 (2007) 801-805
6. Coraci I.S., Husemann J., Berman J.W., Hulette C., Dufour J.H., Campanella G.K., Luster A.D., Silverstein S.C., and El-Khoury J.B. CD36 a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am. J. Pathol. 160 (2002) 101-112
7. Deane R., Du Y.S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., Zhu H., Ghiso J., Frangione B., Stern A., Schmidt A.M., Armstrong D.L., Arnold B., Liliensiek B., Nawroth P., Hofman F., Kindy M., Stern D., and Zlokovic B. RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 9 (2003) 907-913
8. Deane R., Wu Z., and Zlokovic B.V. Rage (Yin) versus LRP (Yang) balance regulates Alzheimer amyloid β-peptide clearance through transport across the blood-brain barrier. Stroke 35 (2004) 2628-2631
9. Donahue J.E., Flaherty S.L., Johanson C.E., Duncan III J.A., Silverberg G.D., Miller M.C., Tavares R., Yang W., Wu Q., Sabo E., Hovanesian V., and Stopa E.G. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol. 112 (2006) 405-415
10. Fryer J.D., DeMattos R.B., McCormick L.M., O'Dell M.A., Spinner M.L., Bales K.R., Paul S.M., Sullivan P.M., Parsadanian M., Bu G., and Holtman D.M. The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice. J. Biol. Chem. 280 (2005) 25754-25759
11. Hayek T., Oiknine J., Brook J.G., and Aviram M. Increased plasma and lipoprotein and lipid peroxidation in APOE-deficient mice. Biochem. Biophys. Res. Commun. 201 (1994) 1567-1574
12. Herz J., and Marschang P. Coaxing the LDL receptor family into the fold. Cell 112 (2003) 289-292
13. Huang C., Liu D., Kameyama K., Nakashima T., Yokomise H., Ueno M., and Miyake M. MRP-1/CD9 gene transduction downregulates Wnt signal pathways. Oncogene 23 (2004) 7475-7483
14. Jeynes B., and Provias J. Evidence for altered LRP/RAGE expression in Alzheimer lesion pathogenesis. Curr. Alzheimer Res. 5 (2008) 432-437
15. Kawamata T., Akiguchi I., Yagi H., Irino M., Sugiyama H., Akiyama H., Shimada A., Takemura M., Ueno M., Kitabayashi T., Ohnishi K., Seriu N., Higuchi K., Hosokawa M., and Takeda T. Neuropathological studies on strains of senescence-accelerated mice (SAM) with age-related deficits in learning and memory. Exp. Gerontol. 32 (1997) 161-169
16. LaDu M.J., Shah J.A., Reardon C.A., Getz G.S., Bu G., Hu J., Guo L., and van Eldik L.J. Apolipoprotein E receptors mediate the effects of β-amyloid on astrocyte cultures. J. Biol. Chem. 275 (2000) 33974-33980
17. Lam F.C., Liu R., Lu P., Shapiro A.B., Renoir J.M., Sharom F.J., and Reiner P.B. Beta-amyloid efflux mediated by p-glycoprotein. J. Neurochem. 76 (2001) 1121-1128
18. Le Y., Gong W., Tiffany H.L., Tumanov A., Nedospasov S., Shen W., Dunlop N.M., Gao J.L., Murphy O.M., Oppenheim J.J., and Wang J.M. Amyloid(beta)42 activates a G-protein-coupled chemoattractant receptor, FRP-like-1. J. Neurosci. 21 (2001) RC123-R127
19. Lorenzo A., Yuan M., Zhang Z., Paganetti P.A., Sturchler-Pierrat C., Staufenbiel M., Mautino J., Vigo F.S., Sommer B., and Yankner B.A. Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease. Nat. Neurosci. 3 (2000) 460-464
20. Mahley R.W. Apolipprotein E: cholesterol transport protein with expanding role in cell biology. Science 240 (1988) 622-630
21. Miyamoto M., Kiyota Y., Yamazaki N., Nagaoka A., Matsuo T., Nagawa Y., and Takeda T. Age-related change in learning and memory in the senescence-accelerated mouse (SAM). Physiol. Behav. 38 (1986) 399-406
22. Miyata M., and Smith J. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity insults and β-amyloid peptides. Nat. Genet. 14 (1996) 55-61
23. Mori A., Utsumi K., Liu J., and Hosokawa M. Oxidative damage in the senescence-accelerated mouse. Ann. N. Y. Acad. Sci. 854 (1998) 239-250
24. Morley J.E., Kumar V.B., Bernardo A.E., Farr S.A., Uezu K., Tumosa N., and Flood J.F. β-Amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides 21 (2000) 1761-1767
25. Nomura Y., Wang B.X., Qi S.B., Namba T., and Kaneko S. Biochemical changes related to aging in the senescence-accelerated mouse. Exp. Gerontol. 24 (1989) 49-55
26. Park L., Raman K.G., Lee K.J., Lu Y., Ferran Jr. L.J., Chow W.S., Stern D., and Schmidt A.M. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation end products. Nat. Med. 4 (1998) 1025-1031
27. Pitas R.E., Boyles J.K., Lee S.H., Hui D., and Weisgraber K.H. Lipoproteins and their receptors in the central nervous system. J. Biol. Chem. 262 (1987) 14352-14360
28. Poon H.F., Joshi G., Sultana R., Farr S.A., Banks W.A., Morley J.E., Calabrese V., and Butterfield D.A. Antisense directed at the Aβ region of APP decreases brain oxidative markers in aged senescence accelerated mice. Brain Res. 1018 (2004) 86-96
29. Rebeck G.W., Reiter J.S., Strickland D.K., and Hyman B.T. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11 (1993) 575-580
30. Sagare A., Deane R., Bell R.D., Johnson B., Hamm K., Pendu R., Marky A., Lenting P.J., Wu Z., Zarcone T., Goate A., Mayo K., Perlmutter D., Coma M., Zhong Z., and Zlokovic B.V. Clearance of amyloid-β by circulating lipoprotein receptors. Nat. Med. 13 (2007) 1029-1031
31. Schmidt A.M., and Stern D. Atherosclerosis and diabetes: the RAGE connection. Curr. Atheroscler. Rep. 5 (2000) 430-436
32. Schmidt A.M., Yan S.D., Wautier J.-L., and Stern D. Activation of receptor for advanced glycation end products. A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ. Res. 84 (1999) 489-497
33. Shibata M., Yamada S., Kumar M., Calero J., Bading B., Frangione D., Holtzman C., Miller C., Strickland D., Ghiso J., and Zlokovic B. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106 (2000) 1489-1499
34. Takeda T., Hosokawa M., and Higuchi K. Senescence-accelerated mouse (SAM): a novel murine model of accelerated senescence. J. Am. Geriatr. Soc. 39 (1991) 911-919
35. Takeda T., Hosokawa M., Takeshita S., Irino M., Higuchi K., Matsushita T., Tomita Y., Yasuhira K., Hanamoto H., Shimizu K., Ishii M., and Yamamoto T. A new murine model of accelerated senescence. Mech. Ageing Dev. 17 (1981) 183-194
36. Takemura M., Nakamura S., Akiguchi I., Ueno M., Oka N., Ishikawa S., Shimada A., Kimura J., and Takeda T. β/A4 protein like immunoreactive granular structures in the brain of senescence-accelerated mouse. Am. J. Pathol. 142 (1993) 1887-1897
37. Ueno M., Sakamoto H., Kanenishi K., Onodera M., Akiguchi I., and Hosokawa M. Ultrastructural and permeability features of microvessels in the hippocampus, cerebellum and pons of senescence-accelerated mice (SAM). Neurobiol. Aging 22 (2001) 469-478
38. Wautier J.-L., Zoukourian C., Chappey O., Wautier M.-P., Guillausseau P.-J., Cao R., Hori O., Stern D., and Schmidt A.M. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. J. Clin. Invest. 97 (1996) 238-243
39. Wei X., Zhang Y., and Zhou J. Alzheimer's disease-related gene expression in the brain of senescence accelerated mouse. Neurosci. Lett. 268 (1999) 139-142
40. Zlokovic B.V. Clearing amyloid through the blood-brain barrier. J. Neurochem. 89 (2004) 807-811
41. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57 (2008) 178-201